More than 2.5 million patients impacted annually.

$9.1-$11.6 billion in annual healthcare costs.


Hospital-acquired pressure injuries are a preventable condition. Familiar standard interventions include lotions, creams, or specialty beds. Yet incidence rates continue to increase.

DermaTherapy® redefines the standard of care.

The industry's first FDA cleared*, evidence-based** therapeutic silk-like bedding and patient apparel to help to reduce the likelihood of patients developing pressure ulcers.

As cited in the

National Pressure Ulcer Advisory Panel (NPUAP)
Clinical Practice Guideline:

“Consider using silk-like fabrics rather than cotton or cotton-blend fabrics to reduce shear and friction."

Developed by the industry leader in engineered healthcare products, DermaTherapy®'s patented performance is backed by independent clinical studies.

It´s time to redefine the standard of care.
It´s time to put an end to hospital-acquired pressure injuries.

Click here to check out the latest results from DermaTherapy® clinical trials.

Request a sample today

click here